Glutamate release mechanism

The "glutamate release mechanism" refers to the **cellular and molecular processes by which the neurotransmitter glutamate is released from cells—primarily neurons and astrocytes—into the synaptic cleft or extracellular space**. In neurons, this typically occurs via **Ca²⁺–dependent exocytosis of synaptic vesicles** at presynaptic terminals. In astrocytes and other glial cells, multiple mechanisms have been identified for non-vesicular and vesicular glutamate release: > This astrocytic glutamate release can occur through six known mechanisms: (i) reversal of uptake by glutamate transporters; (ii) anion channel opening induced by cell swelling; (iii) Ca²⁺–dependent exocytosis; (iv) exchange via cystine-glutamate antiporter; (v) ionotropic purinergic receptor activation; and (vi) functional unpaired connexons ("hemichannels") on the cell surface[1][7]. Glutamatergic signaling is essential for most excitatory neurotransmission in the brain. After its synaptic action, **glutamate is rapidly cleared from the extracellular space primarily by high-affinity transporters on astrocytes**, preventing neurotoxicity due to excessive stimulation ("excitotoxicity")[4][5]. Dysregulation of these mechanisms contributes to several neurological diseases. The term "glutamate release mechanism" does not refer to a single protein target but rather encompasses a set of cellular processes involving multiple molecular players such as vesicular machinery proteins, transporter proteins like EAATs/GLT1/GLAST1[2][4], ion channels, antiporters, and hemichannels. Because it describes a biological process rather than an individual druggable entity like a receptor or enzyme—and because it lacks specificity regarding any one canonical molecule—the entry should be flagged as incorrect if used as a therapeutic target name.

Other names

Glutamate releaseMechanisms of glutamate releaseGlutamate exocytosisAstrocytic glutamate release